Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Cash from Investing Activities (2013 - 2026)

Xencor (XNCR) posted quarterly Cash from Investing Activities of $26.7 million for Q1 2026, up 95.18% year-over-year from $13.7 million in Q1 2025, and down 62.52% quarter-over-quarter from $71.2 million in Q4 2025.

Analysis

Xencor (XNCR) Cash from Investing Activities (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Cash from Investing Activities for 14 consecutive years, with $26.7 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Investing Activities rose 95.18% year-over-year to $26.7 million; the TTM figure through Mar 2026 stood at $153.0 million (up 676.86% YoY), while the FY2025 annual figure was $140.0 million, up 1878.26% from the prior year.
  • Cash from Investing Activities slipped to $26.7 million in Q1 2026 per XNCR's latest filing, from $71.2 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $71.2 million in Q4 2025 and bottomed at -$203.1 million in Q4 2023.
  • Historically, Cash from Investing Activities has averaged -$4.2 million across 5 years, with a median of $24.5 million in 2022.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities slumped 927.48% — and 2024, when it jumped 4798.65%.
  • Xencor's Cash from Investing Activities stood at $24.5 million in 2022, then plunged by 927.48% to -$203.1 million in 2023, then surged by 128.18% to $57.3 million in 2024, then gained by 24.32% to $71.2 million in 2025, then plunged by 62.52% to $26.7 million in 2026.
  • Business Quant data shows XNCR's Cash from Investing Activities at $26.7 million in Q1 2026, $71.2 million in Q4 2025, and $14.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 329.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -1.66 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -49.35 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -363.46 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -229.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 24.51 Mn
10 Xencor 2.02 Bn 1.65 Bn - 85.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 85.12 Mn
Mar 31, 2026 26.68 Mn
Dec 31, 2025 71.17 Mn
Sep 30, 2025 14.67 Mn
Jun 30, 2025 40.48 Mn
Mar 31, 2025 13.67 Mn
Dec 31, 2024 57.25 Mn
Sep 30, 2024 -163.46 Mn
Jun 30, 2024 66.02 Mn
Mar 31, 2024 32.32 Mn
Dec 31, 2023 -203.13 Mn
Sep 30, 2023 45.33 Mn
Jun 30, 2023 -1.41 Mn
Mar 31, 2023 48.14 Mn
Dec 31, 2022 24.55 Mn
Sep 30, 2022 3.13 Mn
Jun 30, 2022 -75.64 Mn
Mar 31, 2022 -71.76 Mn
Dec 31, 2021 7.86 Mn
Sep 30, 2021 -38.85 Mn